VIDEO: ‘Dropless’ formulation benefits practice, patients

CHICAGO — At the American Academy of Ophthalmology meeting here, Sydney L. Tyson, MD, discusses the advantages and remaining reimbursement challenges in his use of a “dropless” formulation (Imprimis Pharmaceuticals) in cataract surgery in his practice.

Full Story →